Home/Filings/4/0001493152-20-014583
4//SEC Filing

Purcell Richard David Jr. 4

Accession 0001493152-20-014583

CIK 0000849636other

Filed

Aug 3, 8:00 PM ET

Accepted

Aug 4, 2:25 PM ET

Size

5.5 KB

Accession

0001493152-20-014583

Insider Transaction Report

Form 4
Period: 2020-07-31
Purcell Richard David Jr.
SVP - Research & Development
Transactions
  • Award

    Common Stock Options (to purchase shares of Common Stock)

    2020-07-31+5,000,0005,000,000 total
    Exercise: $0.01Exp: 2025-07-31Common Stock (5,000,000 underlying)
Footnotes (1)
  • [F1]These Common Stock Options vest in four equal installments: 25 percent on July 31, 2020 (the grant date), 25 percent on September 30, 2020, 25 percent on December 31, 2020, and 25 percent on March 31, 2021.

Documents

1 file

Issuer

RespireRx Pharmaceuticals Inc.

CIK 0000849636

Entity typeother

Related Parties

1
  • filerCIK 0001639306

Filing Metadata

Form type
4
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 2:25 PM ET
Size
5.5 KB